Zoledronic Can Hinder Metastasis of Prostate Cancer

Zoledronic acid is a type of chemotherapeutic agent used in the treatment of several types of cancers. In one study (1), researchers examined zoledronic acid as a possible treatment for metastatic prostate cancer that failed to respond to hormone therapy.
The study involved 122 participants, each of whom had metastatic prostate cancer. The researchers gave zoledronic acid or a placebo drug to these cancer patients to see if zoledronic acid worked better than giving a placebo drug.
They found that when patients received 4 milligrams of zoledronic acid, there was a decreased chance that the prostate cancer would spread to the bone. They also found that giving this strength of the drug was completely safe, even if it was used for an extended period.

1. Saad F. Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer. JNCI J Natl Cancer Inst (2004) 96 (11): 879-882.

Dr. Adem Gunes